{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:06Z","timestamp":1790803266147,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00105-013-2597-y","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T08:59:45Z","timestamp":1382432385000},"page":"762-767","source":"Crossref","is-referenced-by-count":18,"title":["Spironolacton in dermatologischen Behandlungen","Spironolactone in dermatological treatment"],"prefix":"10.1007","volume":"64","author":[{"given":"C.M.","family":"Salavastru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Tiplica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"2597_CR1","unstructured":"Macdonald F (1997) Dictionary of pharmacological agents. CRC, pp\u00a01832\u20131833"},{"key":"2597_CR2","unstructured":"US Food and Drug administration Website (2013) http:\/\/www.fda.gov (Zugegriffen: 29.06.2013)"},{"key":"2597_CR3","unstructured":"Sawaya ME (2007) Antiandrogens and androgen inhibitors. In: Wolverton SE (ed) Comprehensive dermatologic drug therapy, 2nd edn. Elsevier, pp\u00a0417\u2013435"},{"key":"2597_CR4","first-page":"429","volume":"32","author":"Vellacott","year":"1987","unstructured":"Vellacott ID, O\u2019Brien PM (1987) Effect of spironolactone on premenstrual syndrome symptoms. J Reprod Med 32:429\u2013434","journal-title":"J Reprod Med"},{"key":"2597_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(16)59346-7","volume":"48","author":"Young","year":"1987","unstructured":"Young RL, Goldzieher JW, Elking-Hirsch K (1987) The endocrine effects of spironolactone used as an antiandrogen. Fertil Steril 48:223\u2013228","journal-title":"Fertil Steril"},{"key":"2597_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00003088-198005030-00003","volume":"5","author":"Beermann","year":"1980","unstructured":"Beermann B, Gorschinsky-Grind M (1980) Clinical pharmacokinetic of diuretics. Clin Pharmacokinet 5:221\u2013245","journal-title":"Clin Pharmacokinet"},{"key":"2597_CR7","unstructured":"Wilson J (1996) Androgens. In: Hardman JG, Limbird LE, Molinoff PB et al (eds) Goodman & Gilman\u2019s pharmacological basis of therapeutics, 9. edn. McGraw-Hill, New York, pp\u00a01441\u20131457"},{"key":"2597_CR8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","volume":"119","author":"Chen","year":"2002","unstructured":"Chen W, Thiboutot D, Zouboulis CC (2002) Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol 119:992\u20131007","journal-title":"J Invest Dermatol"},{"key":"2597_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1330467","volume":"133","author":"Choudhry","year":"1992","unstructured":"Choudhry R, Hodginns MB, Van Der Kwast TH et al (1992) Localisation of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous gland and sweat glands. J Endocrinol 133:467\u2013475","journal-title":"J Endocrinol"},{"key":"2597_CR10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/1523-1747.ep12472330","volume":"100","author":"Liang","year":"1993","unstructured":"Liang T, Hoyer S, Yu R et al (1993) Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 100:663\u2013666","journal-title":"J Invest Dermatol"},{"key":"2597_CR11","first-page":"101","volume":"91","author":"Thigpen","year":"1993","unstructured":"Thigpen AE, Silver RI, Guileyardo JM et al (1993) Tissue distribution and ontogeny of steroid 5\u03b1-reductase isoenzyme expression. J Clin Invest 91:101\u2013105","journal-title":"J Clin Invest"},{"key":"2597_CR12","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/1523-1747.ep12317162","volume":"105","author":"Thiboutot","year":"1995","unstructured":"Thiboutot D, Harris G, Iles V et al (1995) Activity of the type 1,5\u03b1-reductase activity exhibits regional differences in isolated sebaceous glands of whole skin. J Invest Dermatol 105:2019\u20132214","journal-title":"J Invest Dermatol"},{"key":"2597_CR13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.76.2.524","volume":"76","author":"Imperato-McGinley","year":"1993","unstructured":"Imperato-McGinley J, Gautier T, Cai LQ et al (1993) The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 76:524\u2013528","journal-title":"J Clin Endocrinol Metab"},{"key":"2597_CR14","first-page":"293","volume":"Endocrinol","author":"Imperato-McGinley","year":"1992","unstructured":"Imperato-McGinley J, Miller M, Wilson JD et al (1992) A cluster of male pseudohermaphrodites with 5\u03b1-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf) 34:293\u2013298","journal-title":"Clin"},{"key":"2597_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/1523-1747.ep12616181","volume":"99","author":"Akamatsu","year":"1992","unstructured":"Akamatsu H, Zouboulis CC, Orfanos CE (1992) Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous gland. J Invest Dermatol 99:509\u2013511","journal-title":"J Invest Dermatol"},{"key":"2597_CR16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0015-0282(16)57848-0","volume":"64","author":"Duffy","year":"1995","unstructured":"Duffy DM, Legros RS, Chang L et al (1995) Metabolism of dihydrotestosterone to 5\u03b1-androstane-3\u03b1,17\u03b2-diol glucuronide is greater in the peripheral compartment then in the splanchnic compartment. Fertil Steril 64:736\u2013739","journal-title":"Fertil Steril"},{"key":"2597_CR17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3346\/jkms.2000.15.6.647","volume":"15","author":"Im","year":"2000","unstructured":"Im S, Lee ES, Kim W et al (2000) Expression of progesterone receptor on human keratinocytes. J Korean Med Sci 15:647\u2013654","journal-title":"J Korean Med Sci"},{"key":"2597_CR18","doi-asserted-by":"crossref","unstructured":"Layton AM (2010) Disorders of the sebaceous glands. In: Burns T, Breathnach S, Cox N et al (eds) Rook\u2019s textbook of dermatology, 8th edn. Wiley-Blackwell, ch\u00a042.9","DOI":"10.1002\/9781444317633.ch42"},{"key":"2597_CR19","unstructured":"Hay RJ, Adriaans BM (2010) Bacterial infections. In: Burns T, Breathnach S, Cox N et al (eds) Rook\u2019s textbook of dermatology, 8th edn. Wiley-Blackwell, pp\u00a0ch\u00a030.77\u201330.79"},{"key":"2597_CR20","doi-asserted-by":"crossref","unstructured":"Messenger AG, Berker DAR de, Siclair RD (2010) Disorders of hair. In: Burns T, Breathnach S, Cox N et al (eds) Rook\u2019s textbook of dermatology, 8th edn. Wiley-Blackwell, ch\u00a066.13","DOI":"10.1002\/9781444317633.ch66"},{"key":"2597_CR21","first-page":"CD000194","volume":"2","author":"Brown","year":"2009","unstructured":"Brown J, Farquhar C, Lee O et al (2009) Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne. Cochrane Data Base Syst Rev 2:CD000194","journal-title":"Cochrane Data Base Syst Rev"},{"key":"2597_CR22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","volume":"56","author":"Strauss","year":"2007","unstructured":"Strauss JS, Krowchuk DP, Leyden JJ et al (2007) Guidelines of care for acne vurgaris management. J Am Acad Dermatol 56:651\u2013663","journal-title":"J Am Acad Dermatol"},{"key":"2597_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","volume":"26","author":"Nast","year":"2012","unstructured":"Nast A, Dreno B, Bettoli V et al (2012) European evidence-based (S3) Guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 26(Suppl 1):1\u201329","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2597_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-3083.2011.04214.x","volume":"26","author":"Preneau","year":"2012","unstructured":"Preneau S, Dreno B (2012) Female acne\u2014a different subtype of teenager acne? J Am Acad Dermatol Venereol 26:277\u2013282","journal-title":"J Am Acad Dermatol Venereol"},{"key":"2597_CR25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2010.08.034","volume":"65","author":"Chiu","year":"2011","unstructured":"Chiu HY, Tsai TF (2011) Topical use of systemic drugs in dermatology: a comprehensive review. J Am Acad Dermatol 65:1048.e1\u2013e22","journal-title":"J Am Acad Dermatol"},{"key":"2597_CR26","first-page":"CD000194","volume":"rev","author":"Farqhar","year":"2003","unstructured":"Farqhar C, Lee O, Toomath R et al (2003) Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne. Cochrane database syst rev: CD000194","journal-title":"Cochrane database syst"},{"key":"2597_CR27","doi-asserted-by":"crossref","unstructured":"Messenger AG, De Berker DA, Sinclair RD (2010) Disorders of hair. In: Burns T, Breathnach S, Cox N et al (eds) Rook\u2019s textbook of dermatology, 8th edn. Wiley-Blackwell, ch\u00a066.80","DOI":"10.1002\/9781444317633.ch66"},{"key":"2597_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","volume":"52","author":"Olsen","year":"2005","unstructured":"Olsen EA, Messenger AG, Shapiro J et al (2005) Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 52:301\u2013311","journal-title":"J Am Acad Dermatol"},{"key":"2597_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2011.10630.x","volume":"165","author":"Sinclair","year":"2011","unstructured":"Sinclair R, Patel M, Dawson TL Jr et al (2011) Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Br J Dermatol 165 (Suppl 3):12\u201318","journal-title":"Br J Dermatol"},{"key":"2597_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1440-0960.2009.00517.x","volume":"50","author":"Yazdabadi","year":"2009","unstructured":"Yazdabadi A, Green J, Sinclair R (2009) Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl. Australas J Dermatol 50:113\u2013114","journal-title":"Australas J Dermatol"},{"key":"2597_CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1472-8206.2010.00916.x","volume":"26","author":"Saha","year":"2012","unstructured":"Saha L, Kaur S, Saha PK (2012) Pharmacotherapy of polycystic ovary syndrome\u2014an update. Fundam Clin Pharmacol 26:54\u201362","journal-title":"Fundam Clin Pharmacol"},{"key":"2597_CR32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/11631880-000000000-00000","volume":"13","author":"Alhusayen","year":"2012","unstructured":"Alhusayen R, Shear NH (2012) Pharmacologic interventions for hidradenitis suppurativa: What does the evidence say? Am J Clin Dermatol 13:283\u2013291","journal-title":"Am J Clin Dermatol"},{"key":"2597_CR33","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/jid.2010.155","volume":"130","author":"Mitts","year":"2010","unstructured":"Mitts TF, Bunda SF, Wang Y, Hinek A (2010) Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin. J Invest Dermatol 130:2396\u20132406","journal-title":"J Invest Dermatol"},{"key":"2597_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000441-200001000-00002","volume":"319","author":"Greenberg","year":"2000","unstructured":"Greenberg A (2000) Diuretic complications. Am J Med Sci 319:10\u201324","journal-title":"Am J Med Sci"},{"key":"2597_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3949\/ccjm.57.3.285","volume":"57","author":"Cumming","year":"1990","unstructured":"Cumming DC (1990) Use of spironolactone in treatment of hirsutism. Cleve Clin J Med 57:285\u2013287","journal-title":"Cleve Clin J Med"},{"key":"2597_CR36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/oxfordjournals.aje.a113416","volume":"116","author":"Danielson","year":"1982","unstructured":"Danielson DA, Jick H, Hunter JR et al (1982) Nonestrogenic drugs and breast cancer. Am J Epidemiol 116:329\u2013332","journal-title":"Am J Epidemiol"},{"key":"2597_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaad.2012.09.034","volume":"68","author":"Tayler","year":"2013","unstructured":"Tayler KH, Zirwas MJ (2013) Pregnancy and dermatologic therapy. J Am Acad Dermatol 68:663\u2013671","journal-title":"J Am Acad Dermatol"},{"key":"2597_CR38","unstructured":"Katz HI (1998) Guide to adverse treatment interaction for skin, hair and nail disorders. Lippincott-Raven, Philadelphia, pp\u00a0160\u2013161"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-013-2597-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-013-2597-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T02:31:43Z","timestamp":1564540303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-013-2597-y"}},"subtitle":["\u201eOn-label-\u201c und Off-label-Indikationen","On and off label indications"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2597"],"URL":"https:\/\/doi.org\/10.1007\/s00105-013-2597-y","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}